NRG
CVS icon

Nemes Rush Group’s CVS Health CVS Stock Holding History

Nemes Rush Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Hold
1,828
– – 0.02% 223
2026
Q1 		$131K Buy
1,828
+106
+6% +$8.17K 0.01% 251
2025
Q4 		$137K Buy
1,722
+82
+5% +$6.46K 0.01% 239
2025
Q3 		$124K Sell
1,640
-100
-6% -$6.85K 0.01% 241
2025
Q2 		$120K Sell
1,740
-7
-0.4% -$459 0.01% 239
2025
Q1 		$118K Hold
1,747
– – 0.01% 242
2024
Q4 		$78.4K Sell
1,747
-7
-0.4% -$393 0.01% 265
2024
Q3 		$140K Buy
1,754
+7
+0.4% +$408 0.02% 183
2024
Q2 		$103K Sell
1,747
-157
-8% -$9.82K 0.01% 222
2024
Q1 		$152K Buy
1,904
+115
+6% +$8.78K 0.02% 181
2023
Q4 		$141K Sell
1,789
-135
-7% -$9.61K 0.02% 188
2023
Q3 		$134K Sell
1,924
-75
-4% -$5.31K 0.02% 187
2023
Q2 		$138K Buy
+1,999
New +$142K 0.02% 192

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Nemes Rush Group's CVS Position: Q2 2026 in Review

Nemes Rush Group held its CVS Health (CVS) position steady in Q2 2026 at 1,828 shares worth $189K. The position accounts for 0.02% of the portfolio, ranked #223.

Nemes Rush Group first reported a position in CVS in Q2 2023 and has held it in 13 quarters since. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Nemes Rush Group held 1,828 shares of CVS Health worth $189K as of Q2 2026.
  • Nemes Rush Group left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.02% of Nemes Rush Group's portfolio in Q2 2026, its #223 holding.
  • Nemes Rush Group first reported a position in CVS Health in Q2 2023 and has held it in 13 quarters since.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.